Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SS-RBX in Stress Urinary Incontinence
NCT00138749Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of esreboxetine in stress urinary incontinence (SUI), sponsored by Pfizer. Started Nov 2004; status: completed.
02
Drugs
esreboxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT00138749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138749.